Fanconi Anemia Pathway Activation by FOXM1 is Critical to Bladder Cancer Recurrence and Anticancer Drug Resistance

Although the 5-year survival rate of patients diagnosed with nonmuscle invasive bladder cancer (NMIBC) has reached 85%, more than 50% of patients suffer from frequent recurrences. To identify molecular targets associated with recurrence of NMIBC, we analyzed gene expression data and found that FOXM1...

Descripción completa

Detalles Bibliográficos
Autores principales: Roh, Yun-Gil, Mun, Jeong-Yeon, Kim, Seon-Kyu, Park, Won Young, Jeong, Mi-So, Kim, Tae Nam, Kim, Won-Tae, Choi, Yung Hyun, Chu, In-Sun, Leem, Sun-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352315/
https://www.ncbi.nlm.nih.gov/pubmed/32486251
http://dx.doi.org/10.3390/cancers12061417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352315/
https://www.ncbi.nlm.nih.gov/pubmed/32486251
http://dx.doi.org/10.3390/cancers12061417

Ejemplares similares